| Literature DB >> 33423650 |
Pupalan Iyngkaran1, Andrew Wilson2, James Wong3, David Prior4, David Kaye5, David L Hare6, Peter Bergin7, Michael Jelinem8.
Abstract
Congestive Heart Failure (CHF) is an emerging epidemic. Within one generation, the medical community has learned much of CHF syndromes. It has two distinct mechanisms, systolic and diastolic abnormalities, to account for the common CHF presentation. It is complex as it challenges the available health care services, resource, and funding models in providing an equitable service across the health continuum. Despite the improvement in many cardiovascular diseases, some CHF outcomes like readmissions and costs have increased. The reinvigoration of evidence- based medicine, the development of health services models of care, and standardisation of disease processes with taxonomies have also occurred within the same time span. These processes, however, need to be linked with health policy as presented in white papers. In this paper, we explore achieving optimal CHF guideline-recommended outcomes as the science approaches realworld translation. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Congestive heart failure; cost-efficacy; health services; health systems.; taxonomy; white-papers
Mesh:
Year: 2021 PMID: 33423650 PMCID: PMC8950449 DOI: 10.2174/1573403X16666210108104945
Source DB: PubMed Journal: Curr Cardiol Rev ISSN: 1573-403X